WO2013015586A3 - Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry - Google Patents

Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry Download PDF

Info

Publication number
WO2013015586A3
WO2013015586A3 PCT/KR2012/005860 KR2012005860W WO2013015586A3 WO 2013015586 A3 WO2013015586 A3 WO 2013015586A3 KR 2012005860 W KR2012005860 W KR 2012005860W WO 2013015586 A3 WO2013015586 A3 WO 2013015586A3
Authority
WO
WIPO (PCT)
Prior art keywords
poultry
salmonellosis
preventing
escherichia coli
vaccine composition
Prior art date
Application number
PCT/KR2012/005860
Other languages
French (fr)
Korean (ko)
Other versions
WO2013015586A9 (en
WO2013015586A2 (en
Inventor
이존화
아군 아툴차우다리
기꾸미쓰다
오인경
Original Assignee
전북대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교산학협력단 filed Critical 전북대학교산학협력단
Publication of WO2013015586A2 publication Critical patent/WO2013015586A2/en
Publication of WO2013015586A9 publication Critical patent/WO2013015586A9/en
Publication of WO2013015586A3 publication Critical patent/WO2013015586A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)

Abstract

The present invention relates to a vaccine for poultry, containing an attenuated Salmonella strain that contains virulence factors of pathogenic Escherichia coli of poultry, and to a vaccine composition using same for preventing and treating colibacillosis and salmonellosis in poultry. The present invention further relates to a method for increasing immune reactions in poultry by inoculating the poultry with said vaccine so as to induce immune reactions in the poultry and thus to prevent colibacillosis and salmonellosis in a safe and effective manner.
PCT/KR2012/005860 2011-07-22 2012-07-23 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry WO2013015586A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110073226A KR101374649B1 (en) 2011-07-22 2011-07-22 Attenuated Salmonella mutants expressing virulence factors of pathogenic Escherichia coli in poultry and Vaccine composition comprising thereof and application for protection and treatment against pathogenic Escherichia coli and Salmonella in poultry
KR10-2011-0073226 2011-07-22

Publications (3)

Publication Number Publication Date
WO2013015586A2 WO2013015586A2 (en) 2013-01-31
WO2013015586A9 WO2013015586A9 (en) 2013-04-04
WO2013015586A3 true WO2013015586A3 (en) 2013-05-23

Family

ID=47601634

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/005860 WO2013015586A2 (en) 2011-07-22 2012-07-23 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry

Country Status (2)

Country Link
KR (1) KR101374649B1 (en)
WO (1) WO2013015586A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101518872B1 (en) * 2013-05-14 2015-05-22 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) Primer set for detection of systemic bacterial diseases of Poultry and PCR kits thereof
KR101856736B1 (en) * 2016-02-29 2018-05-11 (주)비손바이오로직스 Endotoxin-reduced Salmonella trivalent inactivated vaccine composition for preventing fowl typhoid and Salmonellosis
KR20190070457A (en) 2017-12-13 2019-06-21 주식회사 오투파워 Composition for preventing Chicken Colibacillosis comprising chlorine dioxide as supplement for drinking water
CN108992669B (en) * 2018-08-27 2022-03-22 广州汇高生物科技有限公司 Composite yolk antibody composition for preventing and treating respiratory tract infection, aerosol inhalation solution, preparation process and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105099A (en) * 2008-09-22 2008-12-03 브리제 유니버시타이트 브루셀 Live attenuated salmonella vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101151004B1 (en) * 2009-08-31 2012-06-22 전라북도 Vaccine composition for protection and treatment against pathogenic Escherichia coli and Salmonella in cattle by administration of attenuated Salmonella expressing adhesin gene of pathogenic Escherichia coli and vaccination method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080105099A (en) * 2008-09-22 2008-12-03 브리제 유니버시타이트 브루셀 Live attenuated salmonella vaccine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHAUDHARI ATUL A.: "Efficacy of a live recombinant vaccine constructed with attenuated salmonella delivery system expressing antigens for avian pathogenic Escherichia coli in chickens", CHONBUK NATIONAL UNIVERSITY PHD THESIS, 2010 *
OH, IN GYEONG: "Evaluation of systemic and mucosal immune responses in mice administered with novel recombinant Salmonella vaccines for avian pathogenic E.coli", GRADUATED SCHOOL OF CHONBUK NATIONAL UNIVERSITY, 2007 *

Also Published As

Publication number Publication date
WO2013015586A9 (en) 2013-04-04
KR101374649B1 (en) 2014-03-17
KR20130011809A (en) 2013-01-30
WO2013015586A2 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
PH12017501146A1 (en) Chemical mitigants in animal feed and feed ingredients
MX2016009898A (en) Treatments for resistant acne.
MY169328A (en) Compositions for the treatment of dry eye
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2017001379A (en) Antiseptic product, process for preparing same and its use.
WO2012145651A3 (en) Compounds for the treatment of neuropsychiatric disorders
WO2012064806A3 (en) Methods and compositions for unsilencing imprinted genes
NZ703597A (en) Mutant fragments of ospa and methods and uses relating thereto
WO2012097185A3 (en) Omv vaccine against burkholderia infections
PH12016502002A1 (en) Novel bacteriophage and composition comprising same
BR112017009330A2 (en) transgenic plant comprising a polynucleotide encoding a heavy chain antibody variable domain
WO2013015586A3 (en) Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry
MX371095B (en) Metap2 inhibitors and methods of treating obesity.
MX2021002851A (en) Reuse of activated chlorous agent for meat and poultry treatment.
BR112016008895A8 (en) methods for the formation of homoalicylic compounds by the reaction of cyclopropyl vinyl precursors with bronsted acid, and for the formation of ambrox
MX2015001051A (en) Multimeric mannosides, a process for preparing the same and their uses as a drug.
CL2012002902A1 (en) Specific bacteriophage strains against bacteria belonging to the genus vibrio for the prophylaxis and therapy of vibrio anguillarum; and antibacterial composition comprising said strains.
WO2013067531A3 (en) Methods of using microrna 195 in providing neuroprotection
TR201910413T4 (en) Methods for improving asthma symptoms using benralizumab.
WO2015013709A3 (en) Compositions for treating skin thickening
WO2013108041A3 (en) Process and method for the treatment of materials, materials thus obtained and uses of these materials
MX2014009957A (en) Compositions and methods for lowering counts of pathogenic microorganisms in food products.
MX2019011026A (en) Novel pd-l1 targeting dna vaccine for cancer immunotherapy.
MX2018014532A (en) A method of reducing egg contamination.
UA114511C2 (en) Ampicillin resistant texturizing lactic acid bacteria strains

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12817183

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12817183

Country of ref document: EP

Kind code of ref document: A2